HRP20161364T1 - Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima - Google Patents
Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima Download PDFInfo
- Publication number
- HRP20161364T1 HRP20161364T1 HRP20161364TT HRP20161364T HRP20161364T1 HR P20161364 T1 HRP20161364 T1 HR P20161364T1 HR P20161364T T HRP20161364T T HR P20161364TT HR P20161364 T HRP20161364 T HR P20161364T HR P20161364 T1 HRP20161364 T1 HR P20161364T1
- Authority
- HR
- Croatia
- Prior art keywords
- lack
- deficiency
- mitochondrial
- microglobulin
- alpha
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A61K38/1722—Plasma globulins, lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Marine Sciences & Fisheries (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201270538 | 2012-09-05 | ||
| DKPA201270557 | 2012-09-12 | ||
| EP13759995.7A EP2900254B1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
| PCT/EP2013/068270 WO2014037390A1 (en) | 2012-09-05 | 2013-09-04 | Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20161364T1 true HRP20161364T1 (hr) | 2016-12-16 |
Family
ID=49162118
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20161364TT HRP20161364T1 (hr) | 2012-09-05 | 2013-09-04 | Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US10226507B2 (en:Method) |
| EP (1) | EP2900254B1 (en:Method) |
| JP (2) | JP2015533790A (en:Method) |
| KR (1) | KR20150047510A (en:Method) |
| CN (1) | CN104661673A (en:Method) |
| AU (1) | AU2013311714C1 (en:Method) |
| BR (1) | BR112015003957A2 (en:Method) |
| CA (1) | CA2881321A1 (en:Method) |
| DK (1) | DK2900254T3 (en:Method) |
| EA (1) | EA028963B1 (en:Method) |
| ES (1) | ES2599034T3 (en:Method) |
| HR (1) | HRP20161364T1 (en:Method) |
| HU (1) | HUE030559T2 (en:Method) |
| IN (1) | IN2015DN00515A (en:Method) |
| MX (1) | MX357656B (en:Method) |
| NZ (1) | NZ629621A (en:Method) |
| PL (1) | PL2900254T3 (en:Method) |
| PT (1) | PT2900254T (en:Method) |
| SG (1) | SG11201500669SA (en:Method) |
| WO (1) | WO2014037390A1 (en:Method) |
| ZA (1) | ZA201500547B (en:Method) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016204360A (ja) * | 2015-02-25 | 2016-12-08 | エー１エム ファーマ エービーＡ１Ｍ Ｐｈａｒｍａ ＡＢ | 放射性核種療法における腎臓の保護に用いるためのアルファ−１−ミクログロブリン |
| WO2017144674A1 (en) * | 2016-02-25 | 2017-08-31 | A1M Pharma Ab | Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast media |
| US10981963B2 (en) * | 2016-03-18 | 2021-04-20 | Guard Therapeutics International AB | Alpha-1-microglobulin derived proteins and their use |
| GB2566516A (en) | 2017-09-15 | 2019-03-20 | Univ Oxford Innovation Ltd | Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria |
| CN109867717A (zh) * | 2019-04-01 | 2019-06-11 | 山西瑞亚力生物技术有限公司 | 一种血浆中α1微球蛋白的提取方法 |
| CN110452980B (zh) * | 2019-09-23 | 2023-07-28 | 武汉儿童医院 | 一种线粒体脑肌病诊断试剂盒及应用 |
| WO2021062007A1 (en) * | 2019-09-25 | 2021-04-01 | Cytegen Corp. | Treatment of mitochondrial deficits and age-related diseases using blood products |
| CN115575646B (zh) * | 2022-11-21 | 2023-04-28 | 四川大学华西医院 | 一种代谢标志物组在制备预测癫痫发作的试剂盒中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1882331A (zh) * | 2003-11-26 | 2006-12-20 | 塞诺菲-安万特德国有限公司 | 作为心血管风险升高指示剂的肾小管性蛋白尿 |
| PT2614832T (pt) * | 2007-02-12 | 2016-10-18 | A1M Pharma Ab | Diagnóstico de pré-eclâmpsia |
| SI2300614T1 (sl) * | 2008-02-04 | 2016-02-29 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Metode in sestavki za zdravljenje mitohondrijskih motenj |
| PL2638915T3 (pl) * | 2008-07-18 | 2017-04-28 | A1M Pharma Ab | Medyczne zastosowanie zmiatacza wolnych rodników i antyoksydantu alfa-1-mikroglobuliny |
-
2013
- 2013-09-04 EA EA201590503A patent/EA028963B1/ru not_active IP Right Cessation
- 2013-09-04 AU AU2013311714A patent/AU2013311714C1/en not_active Ceased
- 2013-09-04 DK DK13759995.7T patent/DK2900254T3/en active
- 2013-09-04 NZ NZ629621A patent/NZ629621A/en not_active IP Right Cessation
- 2013-09-04 MX MX2015002604A patent/MX357656B/es active IP Right Grant
- 2013-09-04 ES ES13759995.7T patent/ES2599034T3/es active Active
- 2013-09-04 PL PL13759995T patent/PL2900254T3/pl unknown
- 2013-09-04 CN CN201380043567.0A patent/CN104661673A/zh active Pending
- 2013-09-04 PT PT137599957T patent/PT2900254T/pt unknown
- 2013-09-04 JP JP2015530375A patent/JP2015533790A/ja active Pending
- 2013-09-04 IN IN515DEN2015 patent/IN2015DN00515A/en unknown
- 2013-09-04 HU HUE13759995A patent/HUE030559T2/en unknown
- 2013-09-04 WO PCT/EP2013/068270 patent/WO2014037390A1/en active Application Filing
- 2013-09-04 KR KR1020157005748A patent/KR20150047510A/ko not_active Ceased
- 2013-09-04 SG SG11201500669SA patent/SG11201500669SA/en unknown
- 2013-09-04 CA CA2881321A patent/CA2881321A1/en not_active Abandoned
- 2013-09-04 BR BR112015003957A patent/BR112015003957A2/pt not_active Application Discontinuation
- 2013-09-04 EP EP13759995.7A patent/EP2900254B1/en not_active Not-in-force
- 2013-09-04 US US14/423,260 patent/US10226507B2/en not_active Expired - Fee Related
- 2013-09-04 HR HRP20161364TT patent/HRP20161364T1/hr unknown
-
2015
- 2015-01-23 ZA ZA2015/00547A patent/ZA201500547B/en unknown
-
2018
- 2018-08-24 JP JP2018157394A patent/JP2018203756A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN104661673A (zh) | 2015-05-27 |
| IN2015DN00515A (en:Method) | 2015-06-26 |
| NZ629621A (en) | 2015-09-25 |
| US20150258171A1 (en) | 2015-09-17 |
| WO2014037390A1 (en) | 2014-03-13 |
| MX2015002604A (es) | 2015-06-10 |
| SG11201500669SA (en) | 2015-02-27 |
| PT2900254T (pt) | 2016-10-18 |
| HK1210585A1 (en) | 2016-04-29 |
| ES2599034T3 (es) | 2017-01-31 |
| EA201590503A1 (ru) | 2015-06-30 |
| JP2018203756A (ja) | 2018-12-27 |
| KR20150047510A (ko) | 2015-05-04 |
| EP2900254A1 (en) | 2015-08-05 |
| DK2900254T3 (en) | 2016-08-29 |
| AU2013311714A1 (en) | 2015-03-12 |
| PL2900254T3 (pl) | 2017-02-28 |
| CA2881321A1 (en) | 2014-03-13 |
| EP2900254B1 (en) | 2016-08-03 |
| AU2013311714C1 (en) | 2018-01-25 |
| HUE030559T2 (en) | 2017-05-29 |
| AU2013311714B2 (en) | 2017-10-12 |
| EA028963B1 (ru) | 2018-01-31 |
| JP2015533790A (ja) | 2015-11-26 |
| MX357656B (es) | 2018-07-18 |
| BR112015003957A2 (pt) | 2017-08-08 |
| ZA201500547B (en) | 2017-09-27 |
| US10226507B2 (en) | 2019-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20161364T1 (hr) | Alfa-1-mikroglobulin za uporabu za liječenje bolesti povezanih s mitohondrijima | |
| JP2015533790A5 (en:Method) | ||
| Anokhina et al. | Racah coefficients and extended HOMFLY polynomials for all 5-, 6-and 7-strand braids | |
| JP2019504018A5 (en:Method) | ||
| Heer et al. | Population, pensions, and endogenous economic growth | |
| CL2018001996A1 (es) | Composiciones y métodos para modular la expresión del factor b del complemento (divisional de solicitud 2764-16) | |
| PH12018500238B1 (en) | Curable photochromic compositions | |
| EP2906547A4 (en) | COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE HYDROTROP AND AT LEAST ONE ACTIVE SUBSTANCE | |
| BR112022025002A2 (pt) | Compostos, composição agroquímica, uso de composto e método de combate a fungos fitopatogênicos | |
| EP2601168A4 (en) | TREATMENT OF MITOCHONDRIAL DISEASES BY VITAMIN K | |
| MX2019003397A (es) | Metodos para tratar trastornos mitocondriales y metabolicos. | |
| BR112014014334A2 (pt) | máquina de lavar louça | |
| UY34925A (es) | ?composiciones herbicidas que comprenden ácido 4-amino-3- cloro-5-fluoro-6-(4-cloro-2-fluoro-3-metoxifenoil)piridina- 2-carboxílico o un derivado de este y una dimetoxi-pirimidina y derivados de es ta?. | |
| MX2017004523A (es) | Composición de activo suavizante de tela. | |
| MA44492A (fr) | Compositions ophtalmiques comprenant une cyclodextrine en tant qu'agent actif unique | |
| MX383372B (es) | Animales resistentes al virus del sindrome reproductivo y respiratorio porcino. | |
| EP2538946A4 (en) | ANTIVIRAL FORMULATIONS | |
| UY35668A (es) | Derivados de azabencimidazol como agonistas de ampk y composiciones farmacéuticas que los contienen | |
| BR112015013615A2 (pt) | plantas de melão com resistência ao vírus associado ao amarelecimento do melão (myav) | |
| IN2015DN00890A (en:Method) | ||
| BR112022010546A2 (pt) | Disco transversal de uma espiral de centrifugação e centrífuga em espiral de camisa sólida | |
| EP3374442A4 (en) | MONOMERS, POLYMERS AND COATING FORMULATIONS WITH AT LEAST ONE N-HALAMINE PRECURSOR, A CATIONIC CENTER AND A COATING INTEGRATION GROUP | |
| BR112017023264A2 (pt) | composição | |
| BR112013009415A2 (pt) | composto de éter arilóxidihalo-propenil e uso destes | |
| BR112014027301A8 (pt) | Suplemento alimentício de animal de estimação compreendendo um ingrediente sensível |